A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
Titel:
A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
Auteur:
Capdevila, J. Clive, S. Casado, E. Michie, C. Piera, A. Sicart, E. Carreras, M. J. Coronado, C. Kahatt, C. Soto Matos-Pita, A. Fernandez Teruel, C. Siguero, M. Cullell-Young, M. Tabernero, J.